Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 1/20 | 0.49 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.44 |
| ▸ | NPC1 | O15118 | 5/20 | 0.44 |
| ▸ | RAB9A | P51151 | 4/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 5/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | TGFBR1 | P36897 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | CCR1 | P32246 | 2/20 | 0.42 |
| ▸ | CCR5 | P51681 | 2/20 | 0.42 |
| ▸ | CCR8 | P51685 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | METAP1 | P53582 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31614324 | 1.00 | MIF (0.49) | MIFGABRA1KDM4ENPC1RAB9A | |
| SCHEMBL28725157 | 0.88 | MIF (0.51) | MIFGABRA1KDM4ENPC1RAB9A | |
| SCHEMBL31526880 | 0.84 | KDM4E (0.46) | MIFGABRA1KDM4ENPC1RAB9A | |
| SCHEMBL21300596 | 0.84 | KDM4E (0.37) | MIFGABRA1KDM4ENPC1RAB9A | |
| SCHEMBL21295907 | 0.81 | MIF (0.44) | MIFGABRA1KDM4ENPC1RAB9A | |
| SCHEMBL23098922 | 0.81 | KRAS (0.39) | MIFGABRA1KDM4ENPC1RAB9A | |
| SCHEMBL16838922 | 0.80 | MIF (0.49) | MIFGABRA1KDM4ENPC1RAB9A | |
| SCHEMBL30302872 | 0.80 | MIF (0.44) | MIFGABRA1KDM4ENPC1RAB9A | |
| SCHEMBL16553298 | 0.80 | GPR3 (0.59) | KDM4ENPC1RAB9AMAPTSMN1; SMN2 | |
| SCHEMBL30550557 | 0.80 | GPR3 (0.59) | KDM4ENPC1RAB9AMAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110041376-B | Ring metal iridium complex and preparation method and application thereof | 江西师范大学 | 2021-10-29 | — | — | CN | claimed |
| EP-4701391-A2 | HETEROLEPTIC IRIDIUM COMPLEX | Universal Display Corporation (US) | 2026-02-25 | — | — | EP | disclosed |
| US-12550604-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2026-02-10 | — | — | US | disclosed |
| EP-3643721-B1 | HETEROLEPTIC IRIDIUM COMPLEX | UNIVERSAL DISPLAY CORP (US) | 2026-01-28 | — | — | EP | disclosed |
| US-20240180020-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2024-05-30 | — | — | US | disclosed |
| US-11910701-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2024-02-20 | — | — | US | disclosed |
| US-20230309376-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-09-28 | — | — | US | disclosed |
| CN-112028941-B | Heteroleptic iridium complexes | 通用显示公司 | 2023-08-29 | — | — | CN | disclosed |
| US-11637251-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-04-25 | — | — | US | disclosed |
| CN-113121603-B | Phosphorescent iridium complex serving as OLED (organic light emitting diode) doping material and application thereof | 江苏三月科技股份有限公司 | 2023-02-24 | — | — | CN | disclosed |
| US-20140203268-A1 | HETEROLEPTIC IRIDIUM COMPLEX | UNIVERSAL DISPLAY CORPORATION (US) | 2014-07-24 | — | — | US | disclosed |
| US-8722205-B2 | Heteroleptic iridium complex | UNIVERSAL DISPLAY CORPORATION (US) | 2014-05-13 | — | — | US | disclosed |
| EP-2710020-A1 | PHOSPHORESCENT HETEROLEPTIC PHENYLBENZIMIDAZOLE DOPANTS AND NEW SYNTHETIC METHODOLOGY | Universal Display Corporation (US) | 2014-03-26 | — | — | EP | disclosed |
| EP-2650941-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | Nippon Steel & Sumikin Chemical Co., Ltd. (JP) | 2013-10-16 | — | — | EP | disclosed |
| US-20130248845-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2013-09-26 | — | — | US | disclosed |
| WO-2012158851-A1 | PHOSPHORESCENT HETEROLEPTIC PHENYLBENZIMIDAZOLE DOPANTS AND NEW SYNTHETIC METHODOLOGY | UNIVERSAL DISPLAY CORPORATION (US) | 2012-11-22 | — | — | WO | disclosed |
| CN-102439019-A | Heteroleptic iridium complexes | UNIVERSAL DISPLAY CORP | 2012-05-02 | — | — | CN | disclosed |
| EP-2411401-A1 | HETEROLEPTIC IRIDIUM COMPLEX | Universal Display Corporation (US) | 2012-02-01 | — | — | EP | disclosed |
| US-20100244004-A1 | HETEROLEPTIC IRIDIUM COMPLEX | UNIVERSAL DISPLAY CORPORATION (US) | 2010-09-30 | — | — | US | disclosed |
| WO-2010111175-A1 | HETEROLEPTIC IRIDIUM COMPLEX | UNIVERSAL DISPLAY CORPORATION (US) | 2010-09-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11910701-B2 | Organic electroluminescent materials and devices | ICOSLG, PDCD1LG2, NECTIN4 | MIF 2243/4885GABRA1 1335/4885KDM4E 2475/4885 |
| US-20240180020-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | ICOSLG, PDCD1LG2, NECTIN4 | MIF 2243/4885GABRA1 1335/4885KDM4E 2475/4885 |
| US-11637251-B2 | Organic electroluminescent materials and devices | ICOSLG, PDCD1LG2, NECTIN4 | MIF 2243/4885GABRA1 1335/4885KDM4E 2475/4885 |
| US-20230309376-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | ICOSLG, PDCD1LG2, NECTIN4 | MIF 2243/4885GABRA1 1335/4885KDM4E 2475/4885 |
| US-20100244004-A1 | HETEROLEPTIC IRIDIUM COMPLEX | DDT, ICOSLG, PDCD1LG2 | MIF 3224/4885GABRA1 292/4885KDM4E 3232/4885 |
| US-12550604-B2 | Organic electroluminescent materials and devices | ROS1, DNMT3A, PRDM9 | MIF 1375/4885GABRA1 2372/4885KDM4E 299/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.